J2Kbio

제이투케이바이오 · 420570

Materials Chemicals · KOSDAQ

Small-cap

Market cap US$33.8M (₩46.7B)

Overview

J2Kbio makes ingredients used in cosmetics, the raw materials that go into skincare, functional beauty, colour cosmetics, hair, and body-care products.

It supplies these ingredients to cosmetics manufacturers and also provides clinical testing services, evaluating the efficacy of cosmetics, health-functional foods, and beauty devices on behalf of clients. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates two distinct business lines: cosmetic ingredient manufacturing and a clinical-services unit run through a subsidiary.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$23.9M

▼ −0.5% YoY

Operating profit · FY2025

US$2.1M

▼ −19.5% YoY

Net income · FY2025

US$1.9M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$20.6M(₩28.5B)	US$24M(₩33.1B)	US$23.9M(₩33B)
Operating profit	US$4.1M(₩5.6B)	US$2.6M(₩3.6B)	US$2.1M(₩2.9B)
Net income	US$3.5M(₩4.8B)	−US$1.2M(−₩1.7B)	US$1.9M(₩2.7B)

Revenue

FY2023US$20.6M
FY2024US$24M
FY2025US$23.9M

Operating profit

FY2023US$4.1M
FY2024US$2.6M
FY2025US$2.1M

Net income

FY2023US$3.5M
FY2024−US$1.2M
FY2025US$1.9M

Key ratios (FY2025)

ROE

7.9%

Debt/Eq

12.7%

Op. margin

8.9%

Net margin

8.1%

Rev. YoY

▼ −0.5%

Why it matters

The clinical-services business is operated through a separately established subsidiary, giving the group a vertically integrated offering from ingredient supply to efficacy testing.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?